期刊文献+

IGF-Ⅱ/IGF-ⅠR相关信号通路与肝细胞癌靶向治疗 被引量:1

Insulin-like growth factor (IGF)-Ⅱ/IGF-ⅠR related signaling pathway and molecular targeted therapy for hepatocellular carcinoma
下载PDF
导出
摘要 胰岛素样生长因子(insulin-like growth factor,IGF)-Ⅱ/IGFⅡ-ⅠR相关信号通路与肝细胞癌(hepatocellular carcinoma,HCC)发生发展密切相关.IGF-Ⅱ活化可经IGF-ⅠR传递促有丝分裂信号,增加HCC变可能.近来研究显示靶向IGF-Ⅱ或IGF-ⅠR可明显抑制HCC细胞增殖.本文就IGF-Ⅱ和IGF-ⅠR信号通路在肝细胞癌变、转化过程中的作用及作为HCC基因治疗靶目标的研究进展进行了评述. The insulin-like growth factor (IGF)-Ⅱ/IGF-Ⅰreceptor (IGF-ⅠR) related signaling pathway is associated with the development and progression of hepatocellular carcinoma (HCC). Hepatic IGF-Ⅱactivation can deliver a mitogenic signal to IGF-ⅠR to increase the tumorigenic potential of liver cells. Recently, a considerable amount of evidence suggests that targeted inhibition of IGF-Ⅱ and IGF-ⅠR could inhibit the proliferation of hepatoma cells. In this review, we summarize the interaction of IGF-Ⅱ and IGF-ⅠR in hepatocarcinogenesis and evaluate their potential use in molecular targeted therapy for hepatocellular carcinoma.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第29期3009-3014,共6页 World Chinese Journal of Digestology
基金 江苏省自然科学基金资助项目 No.BK2008187~~
关键词 胰岛素样生长因子-Ⅱ 胰岛素样生长因子-Ⅰ受体 分子靶向 肝细胞癌 Insulin-like growth factor-Ⅱ Insulin-like growth factor-Ⅰ receptor Targeted therapy Hepatocellular carcinoma
  • 相关文献

参考文献13

二级参考文献44

共引文献49

同被引文献22

  • 1卢圣爱,陈自平,刘倩,徐昌青,贾欣永,郭荣.胃癌患者血清胰岛素样生长因子-Ⅱ检测及其临床意义[J].中国现代普通外科进展,2007,10(3):216-218. 被引量:7
  • 2Piecewicz SM, Pandey A, Roy B, et al. Insulin-like growth factors promote vasculogenesis in embryonic stem cells [ J ]. PLoS One, 2012, 7(2) :e32191.
  • 3Hori N, Yamane M, Kouno K, et al. Induction of DNA demethyla- tion depending on two sets of Sox2 and adjacent 0ct3/4 binding sites (Sox-Oct motifs) within the mouse H19/insulin-like growth factor 2 (IGF2) imprinted control region I J]. J Biol Chem, 2012, 287 (52) :4400644016.
  • 4Pan Y, He B, Lirong Z, et al. Gene therapy for cancer through ade- novirus vectormediated expression of the Ad5 early region gene 1 A based on loss of IGF2 imprinting[J]. Oncol Rep, 2013, 30(4): 1814-1822.
  • 5Davis FM, Azimi I, Faville RA, et al. Induction of epithelial-mesen- chymal transition (EMT) in breast cancer ceils is calcium signal de- pendent[ J]. Oneogene, 2013. [ Epub ahead of printS.
  • 6Sherry PJ, Movva S, Pasupuleti N, et al. Regulation of IGF2 tran- script and protein expression by altered methylation in breast cancer [J]. J Cancer Res Clin Oncol, 2011, 137(2) :339-345.
  • 7Zuo QS, Yan R, Feng DX, et al. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer [J]. Mol Carcinog, 2011, 50(5):390-396.
  • 8Lu Y, Lu P, Zhu Z, et al. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer[J-. J Exp Clin Cancer Res, 2009, 28: 125.
  • 9Tian F, Tang Z, Song G, et al. Loss of imprinting of IGF2 corre- lates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients[J-. Mol Med Rep, 2012, 5(6) :1536-1540.
  • 10Vivanco I, Sawers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer[ J]. Nat Rev Cancer, 2002, 2 (7) :489- 501.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部